Catalyst Wire Dossier Catalyst Wire Dossier

CardioGen-82

Rubidium chloride RB-82 · Bracco Diagnostics Inc
Drug timelines are a Plus or Pro feature.

10 regulatory and trial events tracked for CardioGen-82, covering 2009-07-21 to 2024-12-23. Get the full timeline:

Most recent: FDA Approved: CARDIOGEN-82 — Supplemental Application (Bracco Diagnostics Inc)

See pricing